|
(PQD1) Treatment-emergent resistance to NEDD8-activating enzyme inhibition
|
1R01CA180150-01
|
$558,328
|
$558,328
|
Petroski, Matthew
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
|
(PQD2) Why is Endemic Burkitt Lymphoma Curable with Single Agent Chemotherapy?
|
1R21CA180097-01
|
$165,300
|
$165,300
|
Dittmer, Dirk
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
A bifunctional nanomedicine for both specific imaging and targeting therapy of an
|
5R01CA151955-04
|
$291,367
|
$291,367
|
ZU, YOULI
|
METHODIST HOSPITAL RESEARCH INSTITUTE
|
|
A cohort study among workers exposed to benzene in China
|
ZIA CP010120-02060
|
$425,790
|
$85,158
|
Rothman, Nat
|
DCEG (NCI)
|
|
A Fourth Outcome: DNA Damage and the Differentiation of B Cells
|
5R01CA156674-03
|
$295,991
|
$295,991
|
TEITELL, MICHAEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1
|
ZIA BC 011064
|
$140,721
|
$28,144
|
Mock, Beverly
|
CCR (NCI)
|
|
A multi-center international hospital-based case-control study of lymphoma in Asi
|
ZIA CP010136-10512
|
$1,147,653
|
$1,147,653
|
Lan, Qing
|
DCEG (NCI)
|
|
A MULTILEVEL APPROACH TO ENERGY BALANCE AND CANCER ACROSS THE LIFECOURSE
|
5U54CA155496-03
|
$1,666,218
|
$449,879
|
COLDITZ, GRAHAM
|
WASHINGTON UNIVERSITY
|
|
A new technology to isolate RNP complexes of a polycistronic miRNA oncogene
|
1R21CA175560-01
|
$166,256
|
$166,256
|
He, Lin
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
A novel NKG2D-specific BiTE cancer immunotherapy
|
1R01CA164178-01A1
|
$335,113
|
$167,557
|
Sentman, Charles
|
DARTMOUTH COLLEGE
|
|
A prospective analysis of peripheral blood cytokines and non-Hodgkin lymphoma
|
5R01CA149445-03
|
$560,228
|
$560,228
|
BIRMANN, BRENDA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
A Role for KSHV in the Pathogenesis of Malignancies
|
ZIA SC 010356
|
$317,388
|
$31,739
|
Tosato, Giovanna
|
CCR (NCI)
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-37S2
|
$12,499
|
$1,000
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-37
|
$7,216,850
|
$577,348
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Academic Training in Medical Oncology
|
3T32CA009297-30S1
|
$65,267
|
$6,527
|
RIBAS, ANTONI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Academic Training in Medical Oncology
|
5T32CA009297-30
|
$317,707
|
$31,771
|
RIBAS, ANTONI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
ACTIVATION OF CELLULAR SIGNALING PATHWAYS BY DNA DOUBLE STRAND BREAKS
|
5R01CA136470-05
|
$299,407
|
$149,704
|
SLECKMAN, BARRY
|
WASHINGTON UNIVERSITY
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$410,416
|
$205,208
|
Aplan, Peter
|
CCR (NCI)
|
|
Adult Leukemia Research Center
|
5P01CA018029-38
|
$3,971,921
|
$357,473
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CAN RES CTR
|
|
AIDS Malignancy Clinical Trials Consortium (AMC)
|
3U01CA121947-07S1
|
$5,600,000
|
$1,120,000
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
AIDS Malignancy Clinical Trials Consortium (AMC)
|
5U01CA121947-07
|
$6,477,537
|
$1,295,507
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor
|
ZIA BC 011415
|
$60,238
|
$19,878
|
Kochenderfer, James
|
CCR (NCI)
|
|
Allotransplant for DOCK8 deficiency
|
ZIA BC 011374
|
$281,811
|
$140,906
|
Hickstein, Dennis
|
CCR (NCI)
|
|
Alpha Radioimmunotherapy for Lymphoma Treatment
|
1R01CA172582-01
|
$679,389
|
$679,389
|
SANDMAIER, BRENDA
|
FRED HUTCHINSON CAN RES CTR
|
|
Alternative Cleavage and Polyadenylation Events as Biomarkers
|
1R03CA167752-01A1
|
$76,000
|
$76,000
|
WAGNER, ERIC
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,287,528
|
$128,753
|
Oberholtzer, J.
|
CCR (NCI)
|
|
Animal Model and Genotyping Core Support Facility
|
ZIC BC 011047
|
$1,107,800
|
$221,560
|
DuBois, Wendy
|
CCR (NCI)
|
|
Annual International Primary CNS Lymphoma Collaborative Group Meeting
|
2R13CA124293-07
|
$7,000
|
$7,000
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Antagonizing oncogenic microRNAs for the elucidation and treatment of lymphoma
|
1F32CA174247-01
|
$49,214
|
$49,214
|
CHENG, CHRISTOPHER
|
YALE UNIVERSITY
|
|
Anthraycline-related cardiotoxicity in long-term survivors of lymphoma
|
1R21CA178344-01
|
$189,963
|
$142,472
|
ARMENIAN, SARO
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Antibody-CpG conjugates for the treatment of B cell lymphoma
|
5R01CA149254-04
|
$291,366
|
$291,366
|
Timmerman, John
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Antibody-interferon fusion proteins for treatment of B-cell malignancies
|
5R01CA162964-03
|
$300,377
|
$300,377
|
MORRISON, SHERIE
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Antibody-mediated Gene Therapy for the Treatment of Cancer
|
5K01CA138559-05
|
$142,677
|
$142,677
|
Daniels, Tracy
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Anticancer drug-induced BH3-only protein.Bak interactions
|
5R01CA166741-02
|
$302,812
|
$302,812
|
KAUFMANN, SCOTT
|
MAYO CLINIC ROCHESTER
|
|
Apoptosis Mechanisms and Human Cancer
|
5R01CA082197-14
|
$234,098
|
$163,869
|
WANG, HONG-GANG
|
PENNSYLVANIA STATE UNIVERSITY
|
|
Approaches to discover and quantify apoptotic biomarkers for cancer treatment
|
5R01CA154802-03
|
$301,352
|
$150,676
|
WELLS, JAMES
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-35S1
|
$75,000
|
$2,250
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-35
|
$3,676,771
|
$110,303
|
CRESS, ANNE
|
UNIVERSITY OF ARIZONA
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,207,080
|
$132,779
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor
|
ZIA BC 011413
|
$30,119
|
$22,589
|
Kochenderfer, James
|
CCR (NCI)
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIG BC 010856
|
$14,465,171
|
$723,259
|
Custer, Mary
|
CCR (NCI)
|
|
Basis for Lymphomagenesis in Akt2 Transgenic Mice
|
7R01CA077429-14
|
$374,544
|
$187,272
|
Testa, Joseph
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-24
|
$486,165
|
$4,862
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-07S1
|
$75,000
|
$750
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-07S2
|
$43,265
|
$433
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-07
|
$3,092,811
|
$30,928
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Bcl-2 function on the endoplasmic reticulum
|
5R01CA085804-14
|
$267,381
|
$106,952
|
DISTELHORST, CLARK
|
CASE WESTERN RESERVE UNIVERSITY
|
|
BCR Signaling in ABC DLBCL
|
ZIA BC 011354
|
$71,827
|
$71,827
|
Wilson, Wyndham
|
CCR (NCI)
|
|
BETR Therapy for Herpesvirus-Associated Tumors
|
5R01CA138636-04
|
$1
|
$1
|
POMPER, MARTIN
|
JOHNS HOPKINS UNIVERSITY
|
|
Biobehavioral Mechanisms Facilitating Recovery From Stem Cell Transplantation
|
5K07CA136966-03
|
$148,785
|
$50,587
|
Costanzo, Erin
|
UNIVERSITY OF WISCONSIN-MADISON
|
Total relevant funding to Non Hodgkins Lymphoma for this search: $113,698,866
|